RETINA-READ-RISK

In our latest communication, we highlighted the remarkable efforts of E-Seniors, a dedicated team within our consortium, committed to supporting Parisian seniors aged 55 and over. They orchestrated a series of enlightening focus group sessions in Paris, France, where they introduced our innovative device designed to address the risks associated with diabetic retinopathy. These four sessions weren't merely showcases of our state-of-the-art technology. They also served as invaluable forums for discussing the paramount importance of eye health and gathering feedback from our esteemed participants. “At E-Seniors, we're dedicated to empowering individuals aged 55 and over with technology skills for their well-being. Through the Retina Read Risk project, we introduced an innovative tool for detecting a commonly overlooked illness and raised awareness about its risks among our community. The reaction from senior citizens was extremely positive: many stressed the usefulness of this presentation in raising awareness of a disease whose effects they had little prior knowledge of, and of the importance of getting tested. This awareness is crucial in the fight against diabetic retinopathy and in promoting eye health.” Olivier Rappaport, European project manager at E-Seniors   We extend our heartfelt gratitude to each participant for their invaluable contributions.   For those eager to delve deeper into the intricacies of our project, we invite you to explore the link provided below.   https://lnkd.in/eT4j8sxV   Furthermore, rest assured that E-Seniors remains steadfast in its commitment to sharing the invaluable insights garnered with our esteemed project partners. Together, we persist in our endeavor to refine this game-changing tool for the betterment of diabetic patients worldwide.   Join us on this journey of healthcare innovation and stay tuned for further updates as we continue to make impactful strides in the field. #IISPV #GeneralitatDeCatalunya #InstitutCatalaDeLaSalud #AssociationESeniors #TRCGROUP #Telephonica #FondationDeLavenir #GenesisBiomed #Retinopathy #Diabete #Ophtalmology #Ehealth #IA

In our latest communication, we highlighted the remarkable efforts of E-Seniors, a dedicated team within our consortium, committed to supporting Parisian seniors aged 55 and over. They orchestrated a series of enlightening focus group sessions in Paris, France, where they introduced our innovative device designed to address the risks associated with diabetic retinopathy. These four sessions weren't merely showcases of our state-of-the-art technology. They also served as invaluable forums for discussing the paramount importance of eye health and gathering feedback from our esteemed participants. “At E-Seniors, we're dedicated to empowering individuals aged 55 and over with technology skills for their well-being. Through the Retina Read Risk project, we introduced an innovative tool for detecting a commonly overlooked illness and raised awareness about its risks among our community. The reaction from senior citizens was extremely positive: many stressed the usefulness of this presentation in raising awareness of a disease whose effects they had little prior knowledge of, and of the importance of getting tested. This awareness is crucial in the fight against diabetic retinopathy and in promoting eye health.” Olivier Rappaport, European project manager at E-Seniors   We extend our heartfelt gratitude to each participant for their invaluable contributions.   For those eager to delve deeper into the intricacies of our project, we invite you to explore the link provided below.   https://lnkd.in/eT4j8sxV   Furthermore, rest assured that E-Seniors remains steadfast in its commitment to sharing the invaluable insights garnered with our esteemed project partners. Together, we persist in our endeavor to refine this game-changing tool for the betterment of diabetic patients worldwide.   Join us on this journey of healthcare innovation and stay tuned for further updates as we continue to make impactful strides in the field. #IISPV #GeneralitatDeCatalunya #InstitutCatalaDeLaSalud #AssociationESeniors #TRCGROUP #Telephonica #FondationDeLavenir #GenesisBiomed #Retinopathy #Diabete #Ophtalmology #Ehealth #IA

🔝🔬👏🆕 La #innovació en salut de l’#IISPV Universitat Rovira i Virgili Salut Sant Joan Reus - Baix Camp ICS Ebre Gerència Territorial Terres de l'Ebre, al MWC Barcelona! 👉Els projectes més innovadors de l’#IISPV han estat presents, aquests dies, al @MWC Barcelona. En concret, hi hem portat: 1. RETINA-READ-RISK: https://lnkd.in/ejeyqh3N 2. #EmmaMolds: https://lnkd.in/eskXXzs4 3. Biosfer Teslab: https://lnkd.in/ezPW7aBU Més informació a: https://bit.ly/4356dzR

Second day at #4YFN has just finished as we continue fostering synergies and connecting with different stakeholders from the HealthTech industry! Our mission at Xartec Salut and Research Centre for Biomedical Engineering is to promote technology transfer within the Catalan ecosystem. There are still 2 days left, so if you want to know more about Xartec Salut, come to visit us at our booth with i4KIDS I i4KIDS-EUROPE Cédric Labay Cristina Páez Avilés Universitat Politècnica de Catalunya (UPC) Innovació UPC Biocat, BioRegion of Catalonia Institut d’Investigació Sanitària Pere Virgili - IISPV RETINA-READ-RISK Vincer.AI Pol Solà-Santos AGAUR Generalitat de Catalunya 4YFN Mobile World Capital Barcelona

The Retina Read Risk consortium wishes you a wonderful and enriching year 2024.   In the realm of collaborative innovation, the Retina Read Risk project was initiated two years ago with a shared vision. The consortium steering this transformative action is a partnership of diverse entities: research laboratories, hospitals, a patient association, a telecommunications pioneer, a solution integrator, a health startup specialist, and a foundation dedicated to applied medical research. Thanks to the commitment and expertise of ophthalmologists, Retina Read Risk is becoming an increasingly concrete solution. In addition, the patient association has been placed at the heart of development, to ensure that patient needs are met. The clinical study launched in Spain in October 2022 has already detected a risk of retinopathy in 307 patients and referred 171 of them for further testing.   The Retina Read Risk project is an ongoing narrative of collaborations, innovations, and commitments. At each stage, the consortium is determined to transform the care of diabetic patients. This activity aligns with the technological development of the solution, which continues to incorporate feedback from stakeholders in the diabetic retinopathy diagnostic device. It also builds on the clinical achievements conducted in Spain. In two years, this has improved the precision, specificity, and sensitivity of the solution's algorithms and leveraged the possibilities offered by the latest telecommunication technologies like 5G. The currently developed prototype stems from a complex architecture, ready to be integrated for routine use by medical personnel.   We are happy to share with you a retrospective of the project’s milestones: you can view it by following this link https://lnkd.in/dyS77xDZ